Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge

Abstract Background There is no well‐established late‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Therefore, we retrospectively determined the efficacy and safety of platinum rechallenge with paclitaxel‐carboplatin and bevacizumab in patients with nonsquamous NSCLC as...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jun Sugisaka, Yukihiro Toi, Yosuke Kawashima, Yutaka Domeki, Tomoiki Aiba, Sachiko Kawana, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawara
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-11-01
coleção:	Thoracic Cancer
Assuntos:	platinum bevacizumab paclitaxel nonsmall cell lung cancer cancer
Acesso em linha:	https://doi.org/10.1111/1759-7714.15107
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!